Insulet (MEX:PODD) Construction In Progress: MXN0 Mil (As of Mar. 2026)


MEX:PODD Insulet Corp MEX:PODD
79 GF Score
Price MXN2,548.13
GF Value MXN6,365.57
Valuation Significantly Undervalued
View Full Analysis

What is Insulet Construction In Progress?

Insulet MEX:PODD 79 Construction In Progress is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:PODD with a GF Score™ of 79/100 and a GF Value™ of MXN6,365.57 (Significantly Undervalued).

Insulet's quarterly construction in progress increased from Sep. 2025 (MXN0 Mil) to Dec. 2025 (MXN3,005 Mil) but then declined from Dec. 2025 (MXN3,005 Mil) to Mar. 2026 (MXN0 Mil).

Insulet's annual construction in progress increased from Dec. 2023 (MXN2,334 Mil) to Dec. 2024 (MXN2,849 Mil) and increased from Dec. 2024 (MXN2,849 Mil) to Dec. 2025 (MXN3,005 Mil).

Insulet Construction In Progress Historical Data

* Premium members only.

The historical data trend for Insulet's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Insulet Construction In Progress Chart

Insulet Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,942.68 2,189.40 2,333.96 2,848.89 3,005.15

Insulet Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 3,005.15 0.00
MEX:PODD
79GF Score
Insulet Corp MEX:PODD
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Insulet Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of MXN0 Mil mean?
Insulet (MEX:PODD) has a Construction In Progress of MXN0 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Insulet and its competitors.
Is Insulet's Construction In Progress too high?
Insulet's current Construction In Progress is MXN0 Mil. Overall, Insulet has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Insulet's Construction In Progress compare to MASI and BRKR?
Insulet's Construction In Progress of MXN0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Medical Devices & Instruments company?
A good Construction In Progress depends on the Medical Devices & Instruments industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Insulet and its competitors. Insulet's current Construction In Progress is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Insulet stock overvalued right now?
Based on GuruFocus' analysis, Insulet (MEX:PODD) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN6,365.57, compared to a current price of MXN2,548.13 — trading 60% below its estimated fair value. The current Construction In Progress is MXN0 Mil. Insulet's overall GF Score™ is 79/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Insulet (MEX:PODD), the current Construction In Progress is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Insulet (MEX:PODD) Overvalued in 2026?

Based on GuruFocus' analysis, Insulet stock appears to be undervalued. The current stock price of MXN2,548.13 is trading 60% below its estimated GF Value™ of MXN6,365.57. GuruFocus considers Insulet to be Significantly Undervalued.

Key valuation signals for MEX:PODD:

  • Construction In Progress: MXN0 Mil
  • GF Value™: MXN6,365.57 vs. price of MXN2,548.13 (60% below fair value)
  • GF Score™: 79/100

No single metric tells the full story. See the MEX:PODD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Insulet Business Description

Address 100 Nagog Park, Acton, MA, USA, 01720
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
79GF Score

Get the complete analysis for MEX:PODD

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN2,548.13
Price
MXN6,365.57
GF Value